[Translation] A randomized, double-blind, active-controlled Phase III clinical study to evaluate the efficacy and safety of intravitreal injection of IBI302 in subjects with neovascular age-related macular degeneration
与2 mg阿柏西普每8周一次治疗相比,8 mg IBI302在新生血管性年龄相关性黄斑变性(nAMD)受试者中的最佳矫正视力( BCVA)变化是否能达到非劣效性
[Translation] Whether IBI302 8 mg achieves non-inferiority in change in best corrected visual acuity (BCVA) compared with aflibercept 2 mg every 8 weeks in subjects with neovascular age-related macular degeneration (nAMD)